NVIDIA Files Q4 13F, Allocates $7.9B to Intel and $2.2B to Synopsys
NVIDIA’s Q4 2025 13F filing revealed investments of $7.9B in Intel (214M shares) and $2.2B in Synopsys (4.8M shares), while divesting from Applied Digital, Arm, Recursion and WeRide. The firm is also poised to invest about $20B in OpenAI’s $100B funding round, underscoring deepening ties within the AI ecosystem.
1. Q4 2025 13F Portfolio Additions
NVIDIA’s Q4 2025 13F filing shows new positions totalling over $7.9B in Intel (214M shares) and $2.2B in Synopsys (4.8M shares), plus a stake in Nokia. These additions represent 61% and 17% of its public equity portfolio, respectively, underscoring focus on CPU and EDA strategic partners.
2. Divestitures and Neocloud Exposures
The firm exited positions in Applied Digital, Arm, Recursion Pharmaceuticals and WeRide, reducing smaller neocloud and biotech exposures. It retained stakes in CoreWeave and Nebius, signalling selective confidence within AI-specific cloud infrastructure.
3. OpenAI $100B Funding Round Participation
NVIDIA is preparing to commit roughly $20B to OpenAI’s $100B funding round at an $850B valuation, reinforcing its partnership with the leading AI research firm and aligning capital allocation with long-term AI model deployment strategies.